Lisa Pieri

7.6k total citations · 1 hit paper
58 papers, 2.6k citations indexed

About

Lisa Pieri is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Lisa Pieri has authored 58 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Genetics, 32 papers in Hematology and 23 papers in Molecular Biology. Recurrent topics in Lisa Pieri's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (47 papers), Eosinophilic Disorders and Syndromes (21 papers) and Kruppel-like factors research (21 papers). Lisa Pieri is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (47 papers), Eosinophilic Disorders and Syndromes (21 papers) and Kruppel-like factors research (21 papers). Lisa Pieri collaborates with scholars based in Italy, United States and Austria. Lisa Pieri's co-authors include Alessandro M. Vannucchi, Paola Guglielmelli, Alberto Bosi, Tiziano Barbui, Alessandro Pancrazzi, Alessandro Rambaldi, Ayalew Tefferi, Animesh Pardanani, Terra L. Lasho and Christy M. Finke and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Lisa Pieri

56 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

2014 493 citations Ayalew Tefferi, Paola Guglielmelli et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Pieri Italy	21	2.2k	1.7k	1.5k	939	82	58	2.6k
Alessandro Pancrazzi Italy	23	2.2k 1.0×	1.7k 1.0×	1.5k 1.0×	936 1.0×	80 1.0×	42	2.5k
Carlos Besses Spain	22	1.4k 0.6×	919 0.5×	845 0.6×	525 0.6×	53 0.6×	78	1.8k
Rakhee Vaidya United States	13	1.6k 0.7×	1.3k 0.7×	897 0.6×	625 0.7×	32 0.4×	43	2.1k
Giada Rotunno Italy	15	1.4k 0.6×	1.2k 0.7×	953 0.6×	499 0.5×	127 1.5×	44	1.7k
Francis Grand United Kingdom	20	1.1k 0.5×	1.3k 0.7×	1.3k 0.9×	555 0.6×	214 2.6×	36	2.3k
Katerina Zoi Greece	16	1.3k 0.6×	1.4k 0.8×	1.5k 1.0×	439 0.5×	165 2.0×	34	2.2k
Ashot S. Harutyunyan Austria	16	1.1k 0.5×	821 0.5×	979 0.7×	373 0.4×	72 0.9×	30	1.5k
Ester Pungolino Italy	16	1.6k 0.7×	1.4k 0.8×	864 0.6×	538 0.6×	9 0.1×	39	2.0k
Domenica Caramazza Italy	19	2.3k 1.0×	1.9k 1.1×	1.3k 0.9×	785 0.8×	62 0.8×	35	2.6k
Alfonso Zaccaria Italy	24	871 0.4×	1.2k 0.7×	385 0.3×	249 0.3×	71 0.9×	116	2.1k

Countries citing papers authored by Lisa Pieri

Since Specialization

Citations

This map shows the geographic impact of Lisa Pieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Pieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Pieri more than expected).

Fields of papers citing papers by Lisa Pieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Pieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Pieri. The network helps show where Lisa Pieri may publish in the future.

Co-authorship network of co-authors of Lisa Pieri

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Pieri. A scholar is included among the top collaborators of Lisa Pieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Pieri. Lisa Pieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Federici, Augusto B., Rita Santoro, Lisa Pieri, et al.. (2024). Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy. Clinical and Applied Thrombosis/Hemostasis. 30. 3005446045–3005446045.

Pieri, Lisa, Silvia Linari, Francesca Salvianti, Monica Attanasio, & Giancarlo Castaman. (2024). Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes. SHILAP Revista de lepidopterología. 3(3).

Castaman, Giancarlo, Silvia Linari, Lisa Pieri, et al.. (2023). Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience. Journal of Clinical Medicine. 12(6). 2317–2317. 8 indexed citations

Mannelli, Francesco, Francesca Gesullo, Giada Rotunno, et al.. (2019). Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis. American Journal of Hematology. 94(8). 845–852. 4 indexed citations

Desterke, Christophe, Christophe Martinaud, Bernadette Guerton, et al.. (2015). Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis. Haematologica. 100(6). 757–767. 6 indexed citations

Martinaud, Christophe, Christophe Desterke, Johanna Konopacki, et al.. (2015). Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis. Genomics Data. 5. 1–2. 4 indexed citations

Barbui, Tiziano, Alessandro M. Vannucchi, Alessandra Carobbio, et al.. (2015). Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO‐criteria and stratified by calendar period of diagnosis. American Journal of Hematology. 90(5). 434–437. 15 indexed citations

Bacci, Stefano, Lorenzo Cinci, Laura Calosi, et al.. (2014). Immunohistochemical analysis of dendritic cells in skin lesions: Correlations with survival time. Forensic Science International. 244. 179–185. 28 indexed citations

Rotunno, Giada, Niccolò Bartalucci, Valentina Carrai, et al.. (2014). Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. Leukemia. 28(9). 1811–1818. 65 indexed citations

10.

Pieri, Lisa, et al.. (2013). Imaging studies in extramedullary hematopoiesis of the spleen. Annals of Hematology. 93(2). 347–349. 2 indexed citations

11.

Tenedini, Elena, Isabella Bernardis, Valentina Artusi, et al.. (2013). Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. Leukemia. 28(5). 1052–1059. 58 indexed citations

12.

Verstovšek, Srđan, Francesco Passamonti, Alessandro Rambaldi, et al.. (2013). A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea. Cancer. 120(4). 513–520. 131 indexed citations

13.

Feenstra, Jelena D. Milosevic, Tiina Berg, Thorsten Klampfl, et al.. (2011). Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. American Journal of Hematology. 87(3). 245–250. 80 indexed citations

14.

Guglielmelli, Paola, Lisa Pieri, Roberta Zini, et al.. (2011). Treatment with Ruxolitinib (INCB018424) Induced Changes of Microrna Expression in Granulocytes of Patients with Polycythemia Vera and Essential Thrombocythemia,. Blood. 118(21). 3852–3852. 1 indexed citations

15.

Tefferi, Ayalew, Terra L. Lasho, Omar Abdel‐Wahab, et al.. (2010). IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia. 24(7). 1302–1309. 251 indexed citations

16.

Merante, Serena, Iria Neri, Cristiana Pascutto, et al.. (2010). The New Italian Mastocytosis Registry.. Blood. 116(21). 3805–3805. 3 indexed citations

17.

Stefano, Valerio De, Tommaso Zà, Elena Rossi, et al.. (2009). Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. American Journal of Hematology. 85(2). 97–100. 53 indexed citations

18.

Pieri, Lisa, Costanza Bogani, Paola Guglielmelli, et al.. (2009). The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera. Haematologica. 94(11). 1537–1545. 51 indexed citations

19.

Vannucchi, Alessandro M., Paola Guglielmelli, Lisa Pieri, Elisabetta Antonioli, & Alberto Bosi. (2009). Treatment options for essential thrombocythemia and polycythemia vera. Expert Review of Hematology. 2(1). 41–55. 4 indexed citations

20.

Vannucchi, Alessandro M., Lisa Pieri, Costanza Bogani, et al.. (2008). Constitutively Activated and Hyper-Sensitive Basophils in Patients with Polycythemia Vera: Role of JAK2V617F Mutation and Correlation with Pruritus. Blood. 112(11). 3714–3714. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact